Nuclear Medicine

Nuclear medicine (also called molecular imaging) includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. Nuclear imaging is achieved by injecting small amounts of radioactive material (radiopharmaceuticals) into patients before or during their scan. These can use sugars or chemical traits to bond to specific cells. The radioactive material is taken up by cells that consume the sugars. The radiation emitted from inside the body is detected by photon detectors outside the body. Computers take the data to assemble images of the radiation emissions. Nuclear images may appear fuzzy or ghostly rather than the sharper resolution from MRI and CT.  But, it provides metabolic information at a cellular level, showing if there are defects in the function of the heart, areas of very high metabolic activity associated with cancer cells, or areas of inflammation, data not available from other modalities. These noninvasive imaging exams are used to diagnose cancer, heart disease, Alzheimer’s and Parkinson’s disease, bone disorders and other disorders. 

RSS icon

Imaging advocacy group finds solution to ‘significant obstacle’ fueling shortages of PET/CT professionals

Demand is growing for the modality, but provider groups, particularly those in private practice, have struggled to meet state regulatory requirements. 

Eli Lilly

Eli Lilly inks deal worth over $1.1B to develop new radiopharmaceuticals

The Indianapolis-based drugmaker can hit the hefty total by reaching certain clinical, regulatory and commercial milestones.

House Representative Neal Dunn

House committee advances key legislation to strengthen pay for diagnostic imaging agents

The FIND Act is supported by several industry stakeholders including ACR and the Society of Nuclear Medicine & Molecular Imaging. 

Financial data showing growing revenue

RadNet sees quarterly revenue climb to ‘record’ $432M with double-digit growth across multiple modalities

Comparing only imaging centers that operated both quarters, MRI volumes increased 10% compared to Q1 of 2023 while PET/CT was up more than 15%. 

Thumbnail

Practice must pay $14M after table collapses under patient during imaging exam, jury rules

The original inciting incident occurred in July 2014, when 58-year-old James Griswold visited the Connecticut provider group for a nuclear stress imaging test. 

Medicare drops AUC requirement for advanced imaging, ASNC celebrates

"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.

brain money alzheimer dementia

Amyloid blood test could eliminate millions in spending on PET imaging for Alzheimer’s

At roughly $5,000 per positron emission tomography exam, experts estimate the U.S. healthcare system could save $9 million (or about $1,432 per patient) on imaging. 

radiology trends lungs imaging graphs

Radiologists produce imitation PET scans via routine CT imaging

“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.  
 

Displaying 41 - 48 of 155

Around the web

Health Imaging
American College of Radiology announces significant expansion of Lung Cancer Screening Registry

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

Health Imaging
AI reduces CT lung cancer screening workload by nearly 80%

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.